Global Zoladex Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Zoladex Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Zoladex is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin releasing hormone agonist (GnRH agonist).
Zoladex (goserelin acetate) Implant is a man-made form of a hormone used in men to treat symptoms of prostate cancer, and in women to treat breast cancer or endometriosis. Zoladex is also used in women to prepare the lining of the uterus for endometrial ablation (a surgery to correct abnormal uterine bleeding).
Zoladex report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Zoladex market is projected to reach US$ 1177 million in 2034, increasing from US$ 1004 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from Prostate Cancer and Breast Cancer are the major drivers for the industry.
The global Zoladex market includes several companies. However, AstraZeneca is in a dominant position in the production market, accounting for over 85% of the market share.
Asia-Pacific is the largest consumption region, with a consumption market share of nearly 60%. Following Asia-Pacific, Europe is the second largest consumption area with a consumption market share of about 15%.
The classification of Zoladex includes 1M Zoladex and 3M Zoladex. The proportion of 1M Zoladex is over 60%.
Moreover, Zoladex is widely used for Prostate Cancer, Breast Cancer, Endometriosis, Fibroids, etc. The most proportion of Zoladex is used for Prostate Cancer, and the proportion is about 45%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zoladex market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
AstraZeneca
TerSera
Segment by Type
1M Zoladex
3M Zoladex
Prostate Cancer
Breast Cancer
Endometriosis
Fibroids
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Zoladex market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Zoladex introduction, etc. Zoladex Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Zoladex market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Zoladex (goserelin acetate) Implant is a man-made form of a hormone used in men to treat symptoms of prostate cancer, and in women to treat breast cancer or endometriosis. Zoladex is also used in women to prepare the lining of the uterus for endometrial ablation (a surgery to correct abnormal uterine bleeding).
Zoladex report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Zoladex market is projected to reach US$ 1177 million in 2034, increasing from US$ 1004 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from Prostate Cancer and Breast Cancer are the major drivers for the industry.
The global Zoladex market includes several companies. However, AstraZeneca is in a dominant position in the production market, accounting for over 85% of the market share.
Asia-Pacific is the largest consumption region, with a consumption market share of nearly 60%. Following Asia-Pacific, Europe is the second largest consumption area with a consumption market share of about 15%.
The classification of Zoladex includes 1M Zoladex and 3M Zoladex. The proportion of 1M Zoladex is over 60%.
Moreover, Zoladex is widely used for Prostate Cancer, Breast Cancer, Endometriosis, Fibroids, etc. The most proportion of Zoladex is used for Prostate Cancer, and the proportion is about 45%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zoladex market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
TerSera
Segment by Type
1M Zoladex
3M Zoladex
Segment by Application
Prostate Cancer
Breast Cancer
Endometriosis
Fibroids
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Zoladex market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Zoladex introduction, etc. Zoladex Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Zoladex market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices